Milestone Pharmaceuticals Inc.
MIST
$1.07
-$0.06-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 134.87% | -84.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 134.87% | -84.61% | |||
| Cost of Revenue | 128.57% | -- | |||
| Gross Profit | 135.27% | -85.51% | |||
| SG&A Expenses | 9.75% | 55.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.57% | 27.11% | |||
| Operating Income | -8.31% | -37.12% | |||
| Income Before Tax | -9.78% | -49.73% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.78% | -49.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.78% | -49.73% | |||
| EBIT | -8.31% | -37.12% | |||
| EBITDA | -8.33% | -37.07% | |||
| EPS Basic | -3.10% | -21.86% | |||
| Normalized Basic EPS | -3.12% | -21.83% | |||
| EPS Diluted | -3.10% | -21.86% | |||
| Normalized Diluted EPS | -3.12% | -21.83% | |||
| Average Basic Shares Outstanding | 6.45% | 22.87% | |||
| Average Diluted Shares Outstanding | 6.45% | 22.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||